RXi Pharmaceuticals Corp. (RXII) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXi Pharmaceuticals Corp. (NASDAQ: RXII) reported Q1 EPS of ($0.19), versus ($0.24) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
